Skip to main content
PureTech Health plc logo

PureTech Health plc — Investor Relations & Filings

Ticker · PRTC ISIN · GB00BPVG5C82 LEI · 213800LVPDNO2Z9T9I39 IL Manufacturing
Open in API
Filings indexed 1,319 across all filing types
Latest filing 2022-08-22 Transaction in Own Shar…
Country GB United Kingdom
Listing IL PRTC

About PureTech Health plc

https://puretechhealth.com/

PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is an RNS announcement (indicated by 'RNS Number : 6844W') from PureTech Health PLC, dated August 22, 2022. The title explicitly states 'Transaction in Own Shares' and details the purchase of ordinary shares as part of a 'Share Buyback Programme'. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS), which covers the company buying back or selling its own shares (share repurchase/issuance). Although it is an RNS filing, the content is highly specific to share repurchase activity, making POS the most accurate classification over the general RNS fallback.
2022-08-22 English
Transaction in Own Shares
Transaction in Own Shares Classification · 99% confidence The document is titled 'Transaction in Own Shares' and explicitly details the purchase of ordinary shares as part of a 'Share Buyback Programme'. It provides specific transaction dates, volumes, and prices. This directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase/issuance), which maps to the filing code POS. The document is a detailed announcement, not just a notification of publication, so RPA/RNS is less appropriate than the specific content code.
2022-08-19 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly announces a 'Transaction in Own Shares' as part of a 'Share Buyback Programme'. It details the date, number of shares purchased, and the price paid. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The presence of the RNS Number and the reference to the London Stock Exchange confirms it is a regulatory announcement, but the specific content dictates the POS classification over the general RNS fallback.
2022-08-18 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is titled 'Transaction in Own Shares' and explicitly details the purchase of ordinary shares by PureTech Health PLC as part of its 'Share Buyback Programme'. It provides specific transaction dates, volumes, and prices. This directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase/issuance), which maps to the filing code POS. Furthermore, the document is distributed via RNS (RNS Number: 2413W) and mentions compliance with Market Abuse Regulation, typical for such corporate actions reported to the exchange.
2022-08-17 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is explicitly titled 'Transaction in Own Shares' and details the purchase of ordinary shares by PureTech Health PLC as part of its 'Share Buyback Programme'. It provides specific transaction dates, volumes, and prices. This directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase/issuance), which maps to the filing code POS. The document is a direct report of the transaction, not an announcement of a report, and its content is highly specific, ruling out general categories like RNS or RPA.
2022-08-15 English
6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed with the SEC by a foreign private issuer, PureTech Health plc. It announces a press release about the sale of shares of a founded entity, Karuna Therapeutics, Inc. The document is short (1768 characters) and primarily serves as an announcement of a press release rather than containing detailed financial data or a full report. It does not contain financial statements or substantive financial analysis. Therefore, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2022-08-09 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.